InvestorsHub Logo
Followers 13
Posts 890
Boards Moderated 0
Alias Born 12/27/2017

Re: None

Saturday, 11/10/2018 12:22:56 AM

Saturday, November 10, 2018 12:22:56 AM

Post# of 3857

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

Nexien Biopharma Inc. (OTC: NXEN) announced it acquired New Jersey-based CRx Bio Holdings. The combined companies will formulate FDA approved cannabinoid therapies with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids.

Alex Wasyl, CEO Nexien Biopharma told us that “The acquisition...is a major step in developing FDA approved cannabinoid therapeutics and optimized delivery system platforms. As a serial life sciences entrepreneur, I founded CRx with this vision, based on my 10 years of research in cannabinoid and related sciences, with the goal of creating real pharmaceutical medicines.”



money.cnn.com/news/newsfeeds/benzinga/articles...
https://tinyurl.com/y9duxx7x

0001011101

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NXEN News